Phase II Study of Alemtuzumab in Combination With Pentostatin in Patients With T-Cell Neoplasms

PURPOSE: To examine the efficacy and safety of the combination of alemtuzumab and pentostatin in patients with T-cell neoplasms. PATIENTS AND METHODS: We treated 24 patients with a variety of T-cell leukemias and lymphomas with a combination of alemtuzumab 30 mg intravenously (IV) three times weekly...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Ravandi, Farhad, Aribi, Ahmed, O'Brien, Susan, Faderl, Stefan, Jones, Dan, Ferrajoli, Alessandra, Huang, Xuelin, York, Sergernne, Pierce, Sherry, Wierda, William, Kontoyiannis, Dimitrios, Verstovsek, Srdan, Pro, Barbara, Fayad, Luis, Keating, Michael, Kantarjian, Hagop
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2009
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881363/
https://ncbi.nlm.nih.gov/pubmed/19805674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.6688
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky